U.S. Clinical Trial: Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Ruxolitinib in Seborrheic Dermatitis

Media coverage

• Title	U.S. Clinical Trial: Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Ruxolitinib in Seborrheic Dermatitis
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	28/03/23
  Persons	Benjamin Ungar